---
title: 'Genetic and Clinical Spectrum of SAMD9 and SAMD9L Syndromes: from Variant
  Interpretation to Patient Management'
date: '2024-10-30'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39475954/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20241031185336&v=2.18.0.post9+e462414
source: Blood
description: SAMD9 and SAMD9L (SAMD9/9L) are paralogous genes encoding antiviral proteins
  that negatively regulate cell proliferation. Heterozygous germline gain-of-function
  (GoF) SAMD9/9L variants cause multisystem syndromes with variable manifestations.
  The unifying features are cytopenia, immunodeficiency, infections, bone marrow failure
  (BMF), myelodysplasia (MDS) and monosomy 7. Non-hematopoietic presentations can
  affect almost every organ system. Growth impairment and adrenal insufficiency are
  ...
disable_comments: true
---
SAMD9 and SAMD9L (SAMD9/9L) are paralogous genes encoding antiviral proteins that negatively regulate cell proliferation. Heterozygous germline gain-of-function (GoF) SAMD9/9L variants cause multisystem syndromes with variable manifestations. The unifying features are cytopenia, immunodeficiency, infections, bone marrow failure (BMF), myelodysplasia (MDS) and monosomy 7. Non-hematopoietic presentations can affect almost every organ system. Growth impairment and adrenal insufficiency are ...